OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
48
Results
Show all
Save search
Copy query
Show results for
Unknown
(48)
Publication Date
Release Date
2025
(12)
2020
(7)
2022
(6)
2018
(4)
2024
(3)
2023
(3)
2021
(2)
2017
(2)
2015
(2)
2012
(2)
2026
(1)
2014
(1)
2013
(1)
2010
(1)
2009
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.
Not available
S-EPMC7003897
|
biostudies-literature
Cite
Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2) through 148 weeks.
Not available
S-EPMC7064936
|
biostudies-literature
Cite
Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study.
Not available
S-EPMC10928726
|
biostudies-literature
Cite
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party.
Not available
S-EPMC12731586
|
biostudies-literature
Cite
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1).
Not available
S-EPMC9823187
|
biostudies-literature
Cite
Genome-wide association study identifies inversion in the
CTRB1-CTRB2
locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.
Not available
S-EPMC6145291
|
biostudies-literature
Cite
COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity-A collaborative international study.
Not available
S-EPMC7537123
|
biostudies-literature
Cite
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2.
Not available
S-EPMC9545614
|
biostudies-literature
Cite
International recommendations for sleep and circadian research in aging and Alzheimer's disease: A Delphi consensus study.
Not available
S-EPMC12572825
|
biostudies-literature
Cite
Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial.
Not available
S-EPMC5668494
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets